| __timestamp | Alpine Immune Sciences, Inc. | Genmab A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 505679000 |
| Thursday, January 1, 2015 | 16054000 | 487656000 |
| Friday, January 1, 2016 | 23316000 | 660876000 |
| Sunday, January 1, 2017 | 10626000 | 874278000 |
| Monday, January 1, 2018 | 28970000 | 1431159000 |
| Tuesday, January 1, 2019 | 35847000 | 2386000000 |
| Wednesday, January 1, 2020 | 27185000 | 3137000000 |
| Friday, January 1, 2021 | 58742000 | 4181000000 |
| Saturday, January 1, 2022 | 70243000 | 5562000000 |
| Sunday, January 1, 2023 | 80904000 | 7630000000 |
| Monday, January 1, 2024 | 9748000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal. Over the past decade, Genmab A/S and Alpine Immune Sciences, Inc. have demonstrated contrasting trajectories in their R&D expenditures.
From 2014 to 2023, Genmab A/S has consistently increased its R&D spending, culminating in a staggering 1,400% rise. By 2023, their investment reached a peak, underscoring their commitment to pioneering cancer therapies.
Alpine Immune Sciences, Inc., while smaller in scale, has shown a commendable 560% increase in R&D expenses over the same period. Their focus on immune system modulation reflects a strategic approach to innovation.
This comparison highlights the diverse strategies within the biotech sector, where both giants and emerging players contribute to groundbreaking advancements.
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
R&D Insights: How Genmab A/S and Dr. Reddy's Laboratories Limited Allocate Funds
Research and Development Investment: Genmab A/S vs Ascendis Pharma A/S
Analyzing R&D Budgets: Genmab A/S vs Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Novavax, Inc.